LGT Group Foundation’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
LGT Group Foundation's PFE Position: Q2 2026 in Review
LGT Group Foundation increased its Pfizer (PFE) stake by 7.3% in Q2 2026, buying an estimated $4.22M and bringing the position to 2,367,455 shares worth $57M. The position accounts for 0.65% of the portfolio, ranked #37.
LGT Group Foundation first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $62M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- LGT Group Foundation held 2,367,455 shares of Pfizer worth $57M as of Q2 2026.
- LGT Group Foundation bought 161,222 Pfizer shares in Q2 2026, an estimated $4.22M.
- Pfizer made up 0.65% of LGT Group Foundation's portfolio in Q2 2026, its #37 holding.
- LGT Group Foundation first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- LGT Group Foundation's Pfizer position peaked at $62M in Q1 2026.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on LGT Group Foundation's 13F filing for Q2 2026, filed 10 Aug 2026.